Skip to main content
FinSpry Logo
FinSpry
CAI logo
CAI
(NASDAQ)
Caris Life Sciences, Inc.
$19.29-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Caris Life Sciences, Inc. (CAI) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Caris Life Sciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$32.43
↑ 68.12% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CAI Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Kyle Mikson
Canaccord Genuity
HoldMaintains
$30.00 → $22.00
Mark Massaro
BTIG
Strong BuyMaintains
$45.00 → $38.00
Michael Ryskin
BofA Securities
BuyReiterates
$35.00
Casey Woodring
JP Morgan
HoldMaintains
$200.00 → $35.00
Patrick B Donnelly
Citi
BuyMaintains
$42.00 → $35.00
Catherine Schulte
Baird
BuyMaintains
$26.00 → $28.00
Vijay Kumar
Evercore ISI Group
BuyMaintains
$38.00 → $34.00
Catherine Schulte
Baird
BuyInitiates
$26.00
Patrick B Donnelly
Citi
BuyMaintains
-
Vijay Kumar
Evercore ISI Group
BuyMaintains
$40.00 → $38.00

Frequently Asked Questions

What is the analyst consensus rating for CAI?

The analyst consensus rating for CAI is "Buy" based on 7 analyst recommendations.

What is the average price target for CAI?

The average 12-month price target for CAI is $32.43, representing an upside of 68.1% from the current price of $19.29.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.